Weiss Ratings Reaffirms "Buy (B-)" Rating for Oppenheimer (NYSE:OPY)

Key Points

• Weiss Ratings has reaffirmed a "Buy (B-)" rating for Oppenheimer (NYSE: OPY), reflecting confidence in the company's financial health and market position.
• Oppenheimer's shares were recently upgraded from a "hold" to a "strong-buy" rating by Wall Street Zen, indicating increased analyst optimism about the stock's performance.
• The company reported a net margin of 5.88% and revenue of $373.18 million during its last earnings call, showcasing notable financial results.

Oppenheimer (NYSE:OPY - Get Free Report)'s stock had its "buy (b-)" rating reiterated by Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

Separately, Wall Street Zen upgraded shares of Oppenheimer from a "hold" rating to a "strong-buy" rating in a research report on Sunday, August 10th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, Oppenheimer has a consensus rating of "Buy".

Oppenheimer Trading Down 0.1%

Shares of NYSE:OPY opened at $69.30 on Wednesday. The stock has a market capitalization of $728.98 million, a PE ratio of 8.99 and a beta of 1.18. The firm has a 50 day moving average of $73.47 and a 200-day moving average of $66.47. Oppenheimer has a 12 month low of $47.39 and a 12 month high of $79.99.

Oppenheimer (NYSE:OPY - Get Free Report) last issued its earnings results on Friday, August 1st. The financial services provider reported $1.91 earnings per share (EPS) for the quarter. Oppenheimer had a net margin of 5.88% and a return on equity of 10.13%. The business had revenue of $373.18 million for the quarter.

Insiders Place Their Bets

In related news, insider Dennis P. Mcnamara sold 2,000 shares of Oppenheimer stock in a transaction on Tuesday, August 5th. The shares were sold at an average price of $73.81, for a total value of $147,620.00. Following the sale, the insider owned 21,766 shares in the company, valued at $1,606,548.46. The trade was a 8.42% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 34.25% of the stock is currently owned by company insiders.

Institutional Trading of Oppenheimer

Several large investors have recently added to or reduced their stakes in OPY. Tower Research Capital LLC TRC bought a new stake in shares of Oppenheimer during the 2nd quarter valued at $49,000. Man Group plc boosted its holdings in shares of Oppenheimer by 141.0% during the 2nd quarter. Man Group plc now owns 11,233 shares of the financial services provider's stock valued at $739,000 after buying an additional 6,572 shares in the last quarter. BNP Paribas Financial Markets boosted its holdings in shares of Oppenheimer by 807.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 12,179 shares of the financial services provider's stock valued at $801,000 after buying an additional 10,837 shares in the last quarter. Brevan Howard Capital Management LP bought a new stake in shares of Oppenheimer during the 2nd quarter valued at $282,000. Finally, Bank of America Corp DE boosted its holdings in shares of Oppenheimer by 10.7% during the 2nd quarter. Bank of America Corp DE now owns 25,249 shares of the financial services provider's stock valued at $1,661,000 after buying an additional 2,435 shares in the last quarter. Institutional investors own 32.26% of the company's stock.

Oppenheimer Company Profile

Oppenheimer Holdings Inc operates as a middle-market investment bank and full-service broker-dealer in the Americas, Europe, the Middle East, and Asia. The company provides brokerage services covering corporate equity and debt securities, money market instruments, exchange-traded options and futures contracts, municipal bonds, mutual funds, exchange-traded funds, and unit investment trusts; financial and wealth planning services; and margin lending services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.